Towards a neurophysiological diagnostic marker of Alzheimer's disease using transcranial magnetic stimulation combined with electroencephalography

Abstract

Background

A scalable, objective measure of cortical function that differentiates Alzheimer's disease (AD) from other causes of cognitive impairment is still lacking. Transcranial magnetic stimulation combined with electroencephalography (TMS–EEG) enables direct assessment of cortical reactivity.

Objective

To test whether left primary motor cortex (M1L) P30 amplitude captures AD-related excitability changes, distinguishes biomarker-confirmed AD patients from controls (CN) and from other non-AD causes of cognitive impairment.

Methods

Ninety participants underwent M1L TMS-EEG with Delphi-MD: biomarker-confirmed AD (n = 22), other cognitively impaired (n = 27: vascular/mixed n = 12; frontotemporal dementia n = 4; unknown etiology n = 11), and CN (n = 41).

Results

P30 differed across biomarker-confirmed AD, other cognitively impaired, and CN (Quade F(2,80) = 4.989, p = 0.009, ηp² = 0.11). Pairwise tests showed higher P30 in biomarker-confirmed AD versus other cognitively impaired (t = 2.117, p = 0.037, d = 0.61) and versus CN (t = 3.14, p = 0.002, d = 0.80). Among 27 clinically suspected AD tested for biomarkers, P30 was higher in biomarker + (22/27) versus biomarker− (5/27) (p = 0.035, d = 0.98), had good discriminatory performance for biomarker-confirmed AD (ROC = 0.853 [95% CI_boot 0.627–1.000], p < 0.001), and was not associated with cerebrovascular changes (p = 0.455, d = 0.24).

Conclusions

P30 amplitude is elevated in biomarker-confirmed AD relative to CN and other causes of cognitive impairment, aligning with amyloid-associated cortical hyperexcitability. These findings support P30 as a promising, non-invasive physiological biomarker to aid differential diagnosis and, potentially, disease monitoring in AD.

Trial registry name and URL: https://clinicaltrial.health.gov.il/clinicaltrials/?MOHResearchId=MOH_2022-04-13_010726

Keywords

Alzheimer's disease cortical excitability differential diagnosis TMS evoked potential

Get full access to this article

View all access options for this article.

References

Zhang

Wang

, et al. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 2024; 9: 211.

Ilmoniemi

Kicić

. Methodology for combined TMS and EEG. Brain Topogr 2010; 22: 233–248.

Rogasch

Fitzgerald

. Assessing cortical network properties using TMS-EEG. Hum Brain Mapp 2013; 34: 1652–1669.

Tremblay

Rogasch

Premoli

, et al. Clinical utility and prospective of TMS-EEG. Clin Neurophysiol 2019; 130: 802–844.

Ziemann

Bai

Baumer

, et al. Clinical utility and prospective of TMS-EEG: updated review from an international expert group. Clin Neurophysiol 2026; 184: 2111487.

Rosanova

Casali

Bellina

, et al. Natural frequencies of human corticothalamic circuits. J Neurosci 2009; 29: 7679–7685.

Ferreri

Guerra

Vollero

, et al. TMS-EEG biomarkers of amnestic mild cognitive impairment due to Alzheimer’s disease: a proof-of-concept six years prospective study. Front Aging Neurosci 2021; 13: 737281.

Julkunen

Jauhiainen

Könönen

, et al. Combining transcranial magnetic stimulation and electroencephalography may contribute to assess the severity of Alzheimer’s disease. Int J Alzheimers Dis 2011; 2011: 654794.

Casarotto

Määttä

Herukka

, et al. Transcranial magnetic stimulation-evoked EEG/cortical potentials in physiological and pathological aging. Neuroreport 2011; 22: 592–597.

10.

Bagattini

Mutanen

Fracassi

, et al. Predicting Alzheimer’s disease severity by means of TMS-EEG coregistration. Neurobiol Aging 2019; 80: 38–45.

11.

Julkunen

Jauhiainen

Westerén-Punnonen

, et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer’s disease: a pilot study. J Neurosci Methods 2008; 172: 270–276.

12.

Tautan

Casula

Borghi

, et al. Preliminary study on the impact of EEG density on TMS-EEG classification in Alzheimer’s disease. Annu Int Conf IEEE Eng Med Biol Soc 2022; 2022: 394–397.

13.

Joseph

Knezevic

Zomorrodi

, et al. Dorsolateral prefrontal cortex excitability abnormalities in Alzheimer’s Dementia: findings from transcranial magnetic stimulation and electroencephalography study. Int J Psychophysiol 2021; 169: 55–62.

14.

Casula

Borghi

Maiella

, et al. Regional precuneus cortical hyperexcitability in Alzheimer’s disease patients. Ann Neurol 2023; 93: 371–383.

15.

Ferreri

Vecchio

Vollero

, et al. Sensorimotor cortex excitability and connectivity in Alzheimer’s disease: a TMS-EEG Co-registration study. Hum Brain Mapp 2016; 37: 2083–2096.

16.

Cespón

Pellicciari

Casula

, et al. Age-related changes in cortical excitability linked to decreased attentional and inhibitory control. Neuroscience 2022; 495: 1–14.

17.

Arvanitakis

Shah

Bennett

. Diagnosis and management of dementia: review. JAMA 2019; 322: 1589–1599.

18.

Jack

Andrews

Beach

, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement 2024; 20: 5143–5169.

19.

Borland

Nägga

Nilsson

Minthon

Nilsson

Palmqvist

. The Montreal Cognitive Assessment: normative data from a large Swedish population-based cohort. J Alzheimers Dis 2017; 59: 893–901. doi:10.3233/JAD-170203 21.

20.

Carson

Leach

Murphy

. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry 2018; 33: 379–388. doi:10.1002/gps.4756

21.

Rossini

Burke

Chen

, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol 2015; 126: 1071–1107.

22.

Zifman

Levy-Lamdan

Suzin

, et al. Introducing a novel approach for evaluation and monitoring of brain health across life span using direct non-invasive brain network electrophysiology. Front Aging Neurosci 2019; 11: 248.

23.

Levy-Lamdan

Zifman

Sasson

, et al. Evaluation of white matter integrity utilizing the DELPHI (TMS-EEG) system. Front Neurosci 2020; 14: 589107.

24.

Fogel

Levy-Lamdan

Zifman

, et al. Brain network integrity changes in subjective cognitive decline: a possible physiological biomarker of dementia. Front Neurol 2021; 12: 699014.

25.

Maidan

Zifman

Hausdorff

, et al. A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson’s disease. Parkinsonism Relat Disord 2021; 89: 28–33.

26.

Zifman

Levy-Lamdan

Hiller

, et al. TMS-evoked potentials unveil occipital network involvement in patients diagnosed with Parkinson’s disease within 5 years of inclusion. NPJ Parkinsons Dis 2024; 10: 182.

27.

Davidy

Anis

Suminski

, et al. TMS-evoked potentials: neurophysiological biomarkers for diagnosis and prediction of response to ventriculoperitoneal shunt in normal pressure hydrocephalus. J Clin Neurosci 2025; 136: 111234.

28.

Lassman

Zifman

Fogel

, et al. TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome. Parkinsonism Relat Disord 2024; 130: 107217.

29.

Cline

Lucas

Sun

, et al. Advanced artifact removal for automated TMS-EEG data processing. In: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER), 4–6 May 2021, pp.1039–1042.

30.

Rogasch

Thomson

Farzan

, et al. Removing artefacts from TMS-EEG recordings using independent component analysis: importance for assessing prefrontal and motor cortex network properties. Neuroimage 2014; 101: 425–439.

31.

Metsomaa

Sarvas

Ilmoniemi

. Multi-trial evoked EEG and independent component analysis. J Neurosci Methods 2014; 228: 15–26.

32.

Delorme

Makeig

. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 2004; 134: 9–21.

33.

Jiang

Bian

Tian

. Removal of artifacts from EEG signals: a review. Sensors (Basel) 2019; 19: 987.

34.

Safieddine

Kachenoura

Albera

, et al. Removal of muscle artifact from EEG data: comparison between stochastic (ICA and CCA) and deterministic (EMD and wavelet-based) approaches. EURASIP J Adv Signal Process 2012; 2012: 127.

35.

Soomro

Badruddin

Yusoff

, et al. Automatic eye-blink artifact removal method based on EMD-CCA. In: ICME International Conference on Complex Medical Engineering, Beijing, China, 2013, pp.186–190.

36.

Bortoletto

Veniero

Thut

, et al. The contribution of TMS-EEG coregistration in the exploration of the human cortical connectome. Neurosci Biobehav Rev 2015; 49: 114–124.

37.

Quade

. Rank analysis of covariance. J Am Stat Assoc 1967; 62: 1187–1200.

38.

Joseph

Patterson

Wang

, et al. Quantitative assessment of cortical excitability in Alzheimer’s dementia and its association with clinical symptoms: a systematic review and meta-analyses. J Alzheimers Dis 2022; 88: 867–891.

39.

Lawson

Zomorrodi

Joseph

, et al. Assessing motor cortex excitability and it’s relationship with cortical atrophy in Alzheimer’s dementia. Am J Geriatr Psychiatry 2023; 31: e18–e19.

40.

Verret

Mann

Hang

, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 2012; 149: 708–721.

41.

Palop

Mucke

. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 2016; 17: 777–792.

42.

Busche

Konnerth

. Neuronal hyperactivity–A key defect in Alzheimer’s disease? Bioessays 2015; 37: 624–632.

43.

Stam

de Haan

Daffertshofer

, et al. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer’s disease. Brain 2009; 132: 213–224.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.28 MB